EP-652

N/A

Report date: 2025/03/10 14:25:01
NME

Base Information

Drug NameEP-652
Drug Alias NameEP-652
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionN6-adenosine-methyltransferase catalytic subunit inhibitors
TargetsN6-adenosine-methyltransferase catalytic subunit
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEPICS Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesEPICS Therapeutics SA
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A